Cargando…

The Bethesda System thyroid diagnostic categories in the African-American population in conjunction with surgical pathology follow-up

BACKGROUND: It has been reported that African-Americans (AA) have a higher prevalence of overall malignancy compared to Caucasians, in the United States, yet the incidence of thyroid malignancy is half. The aim of this study is to assess the rate of malignant versus benign thyroid disease in AA from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Archuletta, Pamela Anne, Gidwani, Raja, Husain, Mujtaba, Johnson, Teresa, Shidham, Vinod, Alzohaili, Opada, Bandyopadhyay, Sudeshna, Feng, Jining, Shi, Dongping, Geng, Lili, Tranchida, Paul, Giorgadze, Tamar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327047/ https://www.ncbi.nlm.nih.gov/pubmed/22529875 http://dx.doi.org/10.4103/1742-6413.94274

Ejemplares similares

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
por: Sethi, Seema, et al.
Publicado: (2012)

Etiologic factors related to unsatisfactory ThinPrep(®) cervical cytology: Evaluation and potential solutions to improve
por: Kalinicheva, Tatyana, et al.
Publicado: (2015)

Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy
por: Saleh, Husain A., et al.
Publicado: (2009)

Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules
por: Saleh, Husain A, et al.
Publicado: (2010)

AI diagnosis of Bethesda category IV thyroid nodules
por: Yao, Jincao, et al.
Publicado: (2023)

FRI340 Growth Hormone Deficiency Post Carbon Monoxide Poisoning
por: Ghamlouche, Ahmad Yehia, et al.
Publicado: (2023)

Evaluation of the category high-grade squamous intraepithelial lesion in The Bethesda System for reporting cervical cytology
por: Mukhopadhyay, Subhalakshmi, et al.
Publicado: (2013)

Metastatic colorectal adenocarcinoma in cervicovaginal cytology specimens confirmed by immunocytochemical stains on liquid base specimens: Two study cases with review of the literature
por: Zulfiqar, Muhammad, et al.
Publicado: (2013)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

Pancreaticobiliary tract cytology: Journey toward “Bethesda” style guidelines from the Papanicolaou Society of Cytopathology
por: Layfield, Lester James, et al.
Publicado: (2014)

Does the Bethesda category predict aggressive features in differentiated thyroid cancer?
por: Lima, Ana Rafaela Lopes Reis, et al.
Publicado: (2019)

Diagnostic Efficacy of BRAFV600E Immunocytochemistry in Thyroid Aspirates in Bethesda Category IV and Papillary Thyroid Carcinoma
por: Anand, Nidhi, et al.
Publicado: (2021)

Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
por: Yoo, Mi Ri, et al.
Publicado: (2015)

Associations between Bethesda categories and tumor characteristics of conventional papillary thyroid carcinoma
por: Park, Vivian Youngjean, et al.
Publicado: (2018)

Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid
por: Sung, Simon, et al.
Publicado: (2017)

Third CMAS (CytoJournal Monograph/Atlas Series) titled “Uterine Cervix Cancer and The Bethesda System”
por: Shidham, Vinod B., et al.
Publicado: (2022)

Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System
por: Alrajjal, Ahmed, et al.
Publicado: (2021)

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology
por: Park, So Yoon, et al.
Publicado: (2016)

Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2022)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy*
por: Lourdes Ng, Jennifer, et al.
Publicado: (2023)

A Cross-Sectional Study to Evaluate the Safety and Efficacy of the Insulin Tolerance Test
por: Ghamlouche, Ahmad Yehia, et al.
Publicado: (2021)

Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature
por: Alshaikh, Safa, et al.
Publicado: (2018)

Intraoperative frozen section can be reduced in thyroid nodules classified as Bethesda categories V and VI
por: Huang, Jing, et al.
Publicado: (2017)

Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital
por: Al Dawish, Mohamed, et al.
Publicado: (2020)

Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience
por: Almahari, Sayed Ali, et al.
Publicado: (2019)

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
por: Zahid, Adnan, et al.
Publicado: (2021)

Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III
por: Huang, Jianhao, et al.
Publicado: (2021)

Compensation crisis related to the onsite adequacy evaluation during FNA procedures-Urgent proactive input from cytopathology community is critical to establish appropriate reimbursement for CPT code 88172 (or its new counterpart if introduced in the future)
por: Dhillon, Inderpreet, et al.
Publicado: (2010)

CSI: Bethesda
por: Shaw, Philip
Publicado: (2006)

Leaving Bethesda
por: Kim, Tae-Il
Publicado: (2016)

Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology – An Institutional Experience of 5 Years
por: Upadhyaya, Paricha, et al.
Publicado: (2019)

Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation
por: Huhtamella, Roope, et al.
Publicado: (2019)

The Papanicolaou Society of Cytopathology guidelines for respiratory cytology: Reproducibility of categories among observers
por: Layfield, Lester J., et al.
Publicado: (2018)

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
por: Arul, P., et al.
Publicado: (2015)

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients with Thyroid Nodules Classified As Bethesda Category III
por: Mileva, Magdalena, et al.
Publicado: (2018)

Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype
por: Yoo, Won Sang, et al.
Publicado: (2020)

Pancreatic cyst endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA): Benign or malignant. Clues to cytological diagnosis with major consequences
por: Alrajjal, Ahmed, et al.
Publicado: (2022)

Diagnosis of sebaceous lymphadenoma by fine needle aspiration in a patient with Cowden syndrome: Case report and review of the literature
por: Jazaerly, Tarek, et al.
Publicado: (2014)

Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center
por: Godoi Cavalheiro, Beatriz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bnknder39ttaap6u7s8f96lg9t